Long-term efficacy and updated survival outcomes of sintilimab plus anlotinib in patients with PD-L1-positive recurrent or metastatic cervical cancer.
Saved in:
| Title: | Long-term efficacy and updated survival outcomes of sintilimab plus anlotinib in patients with PD-L1-positive recurrent or metastatic cervical cancer. |
|---|---|
| Authors: | Liu, Jing1 (AUTHOR), Lan, Chunyan2 (AUTHOR), Liu, Tongyu1 (AUTHOR), Liu, Qin3 (AUTHOR), Chang, Lele1 (AUTHOR), Zang, Lele1 (AUTHOR), Zhu, Fei1 (AUTHOR), Zhu, Mingxuan1 (AUTHOR), Zhang, Huiqi1 (AUTHOR), Kang, Yaxin1 (AUTHOR), Wang, Yuqin1 (AUTHOR), Lu, Huaiwu4 (AUTHOR) luhuaiwu@mail.sysu.edu.cn, Sun, Yang1 (AUTHOR) sunyang@fjmu.edu.cn, Xu, Qin1 (AUTHOR) xuqin@fjmu.edu.cn |
| Source: | BMC Medicine. 7/1/2025, Vol. 23 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17417015 |
|---|---|
| DOI: | 10.1186/s12916-025-04198-5 |
